GlassScriptPhysician profile
William P Noble
NPI 1144513748
$4,784.80
in general payments reported to CMS, 2019-2025
30 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $328 · 2023: $1,235 · 2024: $1,511 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,457.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $541.43 | 2023-2025 | |
| Abbvie INC. | $514.96 | 2022-2025 | |
| Lilly USA, LLC | $481.14 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $469.90 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $432.00 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $386.23 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $321.32 | 2022-2025 | Jardiance |
| Bausch Health US, LLC | $295.62 | 2022-2025 | Aplenzin, Wellbutrin |
| Abbott Laboratories | $178.63 | 2022-2025 | Octrode, Freestyle Libre 3, Proclaim |
| Exact Sciences Corporation | $172.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $121.86 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $119.00 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $86.97 | 2023-2025 | Xarelto, Spravato |
| Amgen INC. | $85.79 | 2022-2025 | Repatha, Otezla, Evenity |
| Noven Therapeutics, LLC | $79.91 | 2024 | Xelstrym |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $70.05 | 2024-2025 | Synchromedii, Intellis Adaptivestim |
| Xeris Pharmaceuticals, INC. | $61.90 | 2022 | |
| Merck Sharp & Dohme LLC | $49.70 | 2024-2025 | Gardasil, Gardasil 9, Capvaxive |
| Currax Pharmaceuticals LLC | $45.94 | 2023-2024 | Contrave, Onzetra Xsail |
| Astellas Pharma US INC | $44.32 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $40.05 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.55 | 2023 | Xifaxan |
| Lundbeck LLC | $23.40 | 2025 | Vyepti |
| Corium, LLC | $22.57 | 2025 | Azstarys |
| Esperion Therapeutics, INC. | $21.04 | 2025 | Nexletol |
| Cranial Technologies, INC | $20.53 | 2023 | Doc Band |
| Shield Therapeutics INC | $18.27 | 2023 | Accrufer |
| Tolmar, INC. | $15.99 | 2025 | Jatenzo |
| Biohaven Pharmaceutical Holding Company LTD. | $15.13 | 2022 | |
| Irhythm Technologies, INC. | $12.70 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Noble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.